Esophagus 1 Flashcards
Most common causes of GERD?
Weak LES; increased transient LES relaxations
Demeester score - Based on which test? Abnormal cut off?
PH monitoring; greater than 14.7
PH monitoring - normal acid exposure time? Abnormal?
If symptomatic but normal exposure time, differential?
<4% ; >6%
Reflux hypersensitivity vs functional heartburn ; GERD
Symptom index versus symptom sensitivity index? (Abnormal threshold?)
Reflux related symptoms episodes/total SYMPTOM episodes (>50%)
Reflex related symptoms episodes/total REFLUX episodes (>10%)
Medication more potent than traditional PPIs? Mechanism?
Vonoprazan
Potassium competitive acid blocker (blocks potassium’s ability to engage in ATPase)
Stretta?
Endoscopic radiofrequency non-ablative therapy for GERD
Mechanism unclear
EsophyX?
Endoscopic fundoplication
Refractory GERD - definition?
Persistent heartburn (2+ times/week for three months) despite twice daily PPI
Patient with borderline acid exposure time on pH testing – can still diagnosis GERD if?
Abnormal esophageal biopsy
Abnormal impedance
Positive reflux-symptom association
Frequent reflux episodes>40
Reflux hypersensitivity vs functional heartburn?
Physiologic acid exposure time under 4% WITH positive reflux symptom association
Physiologic acid exposure time under 4% WITHOUT positive reflux symptom association (and normal manometry)
Use of baclofen for this esophageal disease?
Mechanism?
Non-acid reflux with regurgitation
Decreases transient lower esophageal sphincter relaxations (GABA receptor agonist)
Intestinal metaplasia of under 1 cm that replaces the normal stratified squamous epithelium?
1+ cm?
Specialized intestinal metaplasia of the GE junction
Barrett’s esophagus
Historical annual incidence of esophageal adenocarcinoma?
In the long segment Barrett’s without high grade dysplasia? With high grade dysplasia? (Definition of long segment)
- 5% per year
0. 7% per year; 7% year (3 cm)
Who should get screened for Barrett’s esophagus?
Men with GERD symptoms for 5+ years and 2+ of:
- age>50
- white
- central obesity
- smoking history
- relative with Esophageal adenocarcinoma
Difference in biopsies for dysplastic versus non-dysplastic Barrett’s?
q2 vs q1 cm biopsies
Management for Barrett’s esophagus with:
No dysplasia
Indefinite for dysplasia
EGD q3-5 years
optimize PPI therapy and repeat EGD in 3-6 months
Dx and management for Barrett’s esophagus with:
Low-grade dysplasia
High-grade dysplasia
Confirm with repeat EGD within 3-6 months
TX: EGD every year until no dysplasia on two exams OR endoscopic ablation or EMR (If nodular dysplasia)
Confirm with EGD within three months
Tx: Endoscopic ablation or EMR (if nodular dysplasia)
Dx and management for Barrett’s esophagus with:
Esophageal Adenocarcinoma (T1a)
Submucosal esophageal adenocarcinoma (T1b)
Tumor invades lamina propria or muscularis mucosa
Tx: EMR and ablation
Tumor invades submucosa
Tx: EMR and ablation if low risk features (otherwise esophagectomy)
Low risk features for T1b submucosal esophageal adenocarcinoma?
Less than 500 mm invasion into the submucisa
good to moderate differentiation
absence of lymphatic invasion
Recurrence rate of Barrett’s esophagus after radio frequency ablation?
20-30% after 2 years
Criteria for diagnosis of EoE?
- Presence of esophageal symptoms
- > 15 eosinophils per high-powered field or >60 per mm^3)
- Absence of other causes of eosinophilia (GERD, Celiac’s, IBD, achalasia, vasculitis, Connective tissue disease)